Plasmids of corynebacterium glutamicum and derived plasmid vectors.
Abstract
The invention relates to two plasmids isolated from the strain Corynebacterium glutamicum LP-6, deposited under the number DSM 5816, one of which has a high and the other has a low copy number, and from which plasmid vectors capable of autonomous replication in coryneform bacteria (shuttle vectors) can be derived. …<IMAGE>…

Term
Term ended
Projected expiry passed 11 July 2011, 15.2 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
9 claims: 3 independent, 6 dependent
- 1Plasmid pGA1, isoliert aus Corynebacterium glutamicum LP-6, hinterlegt unter der Nummer DSM 5816 charakterisiert durch eine Länge von∼ 49 Kb und folggende Restriktionschnittstellen:
- 2Plasmid pGA2, isoliert aus Corynebacterium glutamicum LP-6, hinterlegt unter der Nummer DSM 5816 charakterisiertdurch eine Länge von ∼ 19,5 Kb und folgende Restriktionsschnittstellen:
- 3Zur autonomen Replikation in coryneformen Bakterien befähigtes rekombinantes Plasmid, konstruiert aus Plasmid pGA1 nach Anspruch 1 durch Hinzufügen mindestens eines Fremd-DNA-Fragments.
- 4Zur autonomen Replikation in coryneformen Bakterien befähigtes rekombinantes Plasmid, konstruiert aus Plasmid pGA2 nach Anspruch 2 durch Hinzufügen mindestens eines Fremd-DNA-Fragments.
- 5Rekombinantes Plasmid (Plasmidvektor) gemäß den Ansprüchen 3 oder 4, zusammengesetzt aus a) dem Plasmid pGA1 oder pGA2 oder einer von diesen Plasmiden abgeleiteten DNA-Sequenz, b) einem DNA-Fragment, abgeleitet von einem in E.coli replizierenden Vektor, das ein Resistenzgen trägt.
- 6Plasmidvektor pHS2-1, gemäß Anspruch 5, bestehend aus dem Plasmid pGA1 und dem E.coli-Vektor pHSKml, charakterisiert durch die Restriktionskarte entsprechend Fig. 4.
- 7Plasmidvektor pFBH2 gemäß Anspruch 5, bestehend aus einer DNA-Sequenz aus pGA2 und dem mobilisierbaren E.coli-Vektor pK18::mob, charakterisiert durch die Restriktionskarte entsprechend Fig. 5 und Fig. 6.
- 8Rekombinantes Plasmid gemäß einem der Ansprüche 3 bis 7, welches zusätzlich ein in coryneformen Bakterien exprimierbares Gen enthält.
- 9Coryneforme Bakterien, welche ein rekombinantes Plasmid gemäß einem der Ansprüche 3 bis 8 enthalten.
Independent claims9
70 paragraphs, as filed
0001New plasmids from Corynebacterium glutamicum and derived plasmid vectors
0002The invention relates to new plasmids from Corynebacterium glutamicum which are compatible and to plasmid vectors (pendulum vectors) derived therefrom. Plasmid vectors are an essential prerequisite for genetic improvement. The construction of plasmid vectors for Corynebacterium or Brevibacterium is generally based on cryptic plasmids, which can be found in this group of bacteria.
0003Plasmid vectors for Corynebacterium and Brevibacterium can be used to clone genes from the biosynthesis of amino acids, to express the corresponding gene product or enzyme to an increased extent and thereby to improve the amino acid secretion. The improvement of the excretion of L-lysine by Corynebacterium glutamicum by cloning and overexpression of the phosphoenolpyruvate carboxylase gene of Corynebacterium glutamicum (European patent application No. 89 114 632.6) may be mentioned as an example.
0004Plasmids are very rarely found in the group of coryneform amino acid-secreting bacteria, even if the literature might give the opposite impression. A closer look reveals that plasmids described under different names have so many identical properties that they can be regarded as identical. Examples are plasmids pAM286 from C.glutamicum AJ11560 (EP-A-0 77 548); pAM330 from B.lactofermentum ATCC13869 (EP-A-0 77 548), pBL1 from B.lactofermentum ATCC21798 (Santamaria, R. et al., J. Gen. Microbiol. 130, 2237-2246 (1984)) and pX18 from B lactofermentum ATCC21086 (Yeh, P. et al., Gene 47, 301-308 (1986)).
0005The same applies to the plasmids pHM1519 from C.glutamicum ATCC13058 (EP-A-0 78 537), pCG1 from C.glutamicum ATCC31808 (EP-A-0 58 889), pRN 3.1 from C.glutamicum ATCC39269 (DE-A-3402876 ) and pSR1 (Yoshihama, M. et al., J.Bact. 162, 591-597 (1985)) from C.glutamicum ATCC 19223. Here too, the high degree of agreement of the data published on the respective plasmids shows the person skilled in the art that it must be the same plasmid species. Martin, JF et al., (Bio / Technology 5, 137-146 (1987)) confirm this assumption.
0006However, the number of publications and patent applications on this topic shows the interest in a variety of plasmids that are suitable for the development of cloning systems for coryneform bacteria.
0007Of particular importance for the development z. B. Amino acid-secreting strains are plasmids that can coexist in one cell.
0008Such compatible plasmids allow combinations of biosynthetic genes to be simultaneously introduced into a microorganism, the desired enzyme activities to be increased and the formation of the desired product such as e.g. B. L-threonine or L-lysine to improve. For example, there are particularly favorable conditions for compatible plasmids, one of which has a high and the other a low number of copies, in order to achieve a balanced overexpression of the respective genes and to avoid unnecessary strain on the host.
0009At the same time, of course, sufficient stability of the plasmids used must also be sought.
0010As is known from the literature, however, there are no compatibility studies (Martin, JF et al., Loc. Cit., 139), just as little as studies on the stability of plasmid vectors. The object of the invention is to use plasmids or To provide plasmid vectors that are compatible and have sufficient stability to improve the methodological requirements for genetic engineering strain improvement, especially of coryneform amino acid-excreting bacteria, beyond the prior art.
0011The invention relates to the plasmid pGA1, isolated from Corynebacterium glutamicum LP-6, deposited under the number DSM 5816, characterized by a length of ∼ 4.9 Kb and the following restriction sites: <tables id="tabl0001" num="0001"><table frame="all"><title>Table 1</title><tgroup cols="3" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="52.50mm" /><colspec colnum="2" colname="col2" colwidth="52.50mm" /><colspec colnum="3" colname="col3" colwidth="52.50mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" align="center">Restriction enzymes</entry><entry namest="col2" nameend="col2" align="center">Number of interfaces</entry><entry namest="col3" nameend="col3" align="center">DNA fragments (Kb)</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">Apa I</entry><entry namest="col2" nameend="col2" align="right">0</entry><entry namest="col3" nameend="col3" align="char" char=",">-</entry></row><row><entry namest="col1" nameend="col1" align="left">Bam HI</entry><entry namest="col2" nameend="col2" align="right">2</entry><entry namest="col3" nameend="col3" align="char" char=",">3,3 1,6</entry></row><row><entry namest="col1" nameend="col1" align="left">Bcl I</entry><entry namest="col2" nameend="col2" align="right">0</entry><entry namest="col3" nameend="col3" align="char" char=",">-</entry></row><row><entry namest="col1" nameend="col1" align="left">Bgl I</entry><entry namest="col2" nameend="col2" align="right">0</entry><entry namest="col3" nameend="col3" align="char" char=",">-</entry></row><row><entry namest="col1" nameend="col1" align="left">Bgl II</entry><entry namest="col2" nameend="col2" align="right">0</entry><entry namest="col3" nameend="col3" align="char" char=",">-</entry></row><row><entry namest="col1" nameend="col1" align="left">Letter E II</entry><entry namest="col2" nameend="col2" align="right">1</entry><entry namest="col3" nameend="col3" align="char" char=",">4,9</entry></row><row><entry namest="col1" nameend="col1" align="left">Cla I</entry><entry namest="col2" nameend="col2" align="right">1</entry><entry namest="col3" nameend="col3" align="char" char=",">4,9</entry></row><row><entry namest="col1" nameend="col1" align="left">Dra I</entry><entry namest="col2" nameend="col2" align="right">0</entry><entry namest="col3" nameend="col3" align="char" char=",">-</entry></row><row><entry namest="col1" nameend="col1" align="left">Eco RI</entry><entry namest="col2" nameend="col2" align="right">1</entry><entry namest="col3" nameend="col3" align="char" char=",">4,9</entry></row><row><entry namest="col1" nameend="col1" align="left">Eco RV</entry><entry namest="col2" nameend="col2" align="right">0</entry><entry namest="col3" nameend="col3" align="char" char=",">-</entry></row><row><entry namest="col1" nameend="col1" align="left">Hind III</entry><entry namest="col2" nameend="col2" align="right">4</entry><entry namest="col3" nameend="col3" align="char" char=",">2,4 1,1 1,05 0,3</entry></row><row><entry namest="col1" nameend="col1" align="left">Kpn I</entry><entry namest="col2" nameend="col2" align="right">0</entry><entry namest="col3" nameend="col3" align="char" char=",">-</entry></row><row><entry namest="col1" nameend="col1" align="left">Mlu I</entry><entry namest="col2" nameend="col2" align="right">3</entry><entry namest="col3" nameend="col3" align="char" char=",">2,45 2,25 0,2</entry></row><row><entry namest="col1" nameend="col1" align="left">Pvu II</entry><entry namest="col2" nameend="col2" align="right">2</entry><entry namest="col3" nameend="col3" align="char" char=",">3,25 1,65</entry></row><row><entry namest="col1" nameend="col1" align="left">Sal I</entry><entry namest="col2" nameend="col2" align="right">0</entry><entry namest="col3" nameend="col3" align="char" char=",">-</entry></row><row><entry namest="col1" nameend="col1" align="left">Sph I</entry><entry namest="col2" nameend="col2" align="right">1</entry><entry namest="col3" nameend="col3" align="char" char=",">4,9</entry></row><row><entry namest="col1" nameend="col1" align="left">Sst I</entry><entry namest="col2" nameend="col2" align="right">0</entry><entry namest="col3" nameend="col3" align="char" char=",">-</entry></row><row><entry namest="col1" nameend="col1" align="left">Xba I</entry><entry namest="col2" nameend="col2" align="right">2</entry><entry namest="col3" nameend="col3" align="char" char=",">2,5 2,4</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Xho I</entry><entry namest="col2" nameend="col2" align="right">0</entry><entry namest="col3" nameend="col3" align="char" char=",">-</entry></row></tbody></tgroup></table></tables>
0012Fig. 1 contains the restriction map of pGA1 in a linear representation.
0013Corynebacterium glutamicum strain LP-6 was obtained from the "Felix d'Herelle Reference Center for Bacterial Viruses" at Quebec 10, Quebec Laval University, Canada GlK 7P4 under the number HER1229. C.glutamicum strain LP-6 was deposited with the German Collection of Microorganisms in Braunschweig, Federal Republic of Germany, in accordance with the Budapest Treaty as DSM 5816.
0014Another object is the pGA1-compatible plasmid pGA2, isolated from Corynebacterium glutamicum LP-6, deposited under the number DSM 5816, characterized by a length of ∼ 19.5 Kb and the following restriction sites: <tables id="tabl0002" num="0002"><table frame="all"><title>Table 2</title><tgroup cols="3" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="52.50mm" /><colspec colnum="2" colname="col2" colwidth="52.50mm" /><colspec colnum="3" colname="col3" colwidth="52.50mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" align="center">Restriction enzymes</entry><entry namest="col2" nameend="col2" align="center">Number of interfaces</entry><entry namest="col3" nameend="col3" align="center">DNA fragments (Kb)</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">Bam HI</entry><entry namest="col2" nameend="col2" align="right">3</entry><entry namest="col3" nameend="col3" align="char" char=",">13,6 4,15 1,75</entry></row><row><entry namest="col1" nameend="col1" align="left">Eco RI</entry><entry namest="col2" nameend="col2" align="right">2</entry><entry namest="col3" nameend="col3" align="char" char=",">18,5 0,96</entry></row><row><entry namest="col1" nameend="col1" align="left">Hind III</entry><entry namest="col2" nameend="col2" align="right">5</entry><entry namest="col3" nameend="col3" align="char" char=",">6,61 5,72 3,31 2,04 1,82</entry></row><row><entry namest="col1" nameend="col1" align="left">Hpa I</entry><entry namest="col2" nameend="col2" align="right">1</entry><entry namest="col3" nameend="col3" align="char" char=",">19,5</entry></row><row><entry namest="col1" nameend="col1" align="left">Kpn I</entry><entry namest="col2" nameend="col2" align="right">1</entry><entry namest="col3" nameend="col3" align="char" char=",">19,5</entry></row><row><entry namest="col1" nameend="col1" align="left">Mlu I</entry><entry namest="col2" nameend="col2" align="right">3</entry><entry namest="col3" nameend="col3" align="char" char=",">15,8 2,84 0,82</entry></row><row><entry namest="col1" nameend="col1" align="left">Sca I</entry><entry namest="col2" nameend="col2" align="right">1</entry><entry namest="col3" nameend="col3" align="char" char=",">19,5</entry></row><row><entry namest="col1" nameend="col1" align="left">Sma I</entry><entry namest="col2" nameend="col2" align="right">4</entry><entry namest="col3" nameend="col3" align="char" char=",">14,5 3,34 1,00 0,65</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Xho I</entry><entry namest="col2" nameend="col2" align="right">0</entry><entry namest="col3" nameend="col3" align="char" char=",">-</entry></row></tbody></tgroup></table></tables>
0015Fig. 2 contains the restriction map of pGA2 in a linear representation.
0016The plasmid DNA can be isolated from the stored strain by methods known to the person skilled in the art.
0017While the plasmid pGA1 has a high copy number (∼50 per cell), a low copy number (∼5) is determined for pGA2.
0018Coryneform bacteria, in particular bacteria producing amino acids, serve as hosts for these plasmids.
0019Examples of coryneform bacteria are: <tables id="tabl0003" num="0003"><table frame="all"><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">Brevibacterium flavum, especially</entry><entry namest="col2" nameend="col2" align="left">ATCC 14067</entry></row><row><entry namest="col1" nameend="col1" align="left">Brevibacterium lactofermentum, especially</entry><entry namest="col2" nameend="col2" align="left">ATCC 13869</entry></row><row><entry namest="col1" nameend="col1" align="left">Corynebacterium callunae, especially</entry><entry namest="col2" nameend="col2" align="left">ATCC 15991</entry></row><row><entry namest="col1" nameend="col1" align="left">Corynebacterium glutamicum, in particular</entry><entry namest="col2" nameend="col2" align="left">ATCC 13032</entry></row><row><entry namest="col1" nameend="col1" align="left">Corynebacterium melassecola, especially</entry><entry namest="col2" nameend="col2" align="left">ATCC 17965</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Corynebacterium thermoaminogenes, especially</entry><entry namest="col2" nameend="col2" align="left">Ferm P-9244</entry></row></tbody></tgroup></table></tables>
0020Since the plasmids according to the invention multiply in the cells of the coryneform bacteria, they are able to amplify the information in the host sites of foreign genes inserted into the plasmids.
0021The incorporation of the recombinant plasmid DNA into the host cells is preferably carried out via composite plasmids (plasmid vectors), for the construction of which are particularly suitable a vector containing resistance gene which replicates in E-coli, such as, for. B. pACYC177, pACYC184, pSC101, pBR322, pIP55, R16, R1, RP4 and pIE545.
0022The principle of such constructions is described in EP-A-93611 and EP-A-82 485.
0023The pendulum vector pHS 2-1, consisting of the plasmid pGA1 and the E. coli vector pHSKml, is particularly suitable, characterized by the restriction map according to FIG. 4.
0024The vector pHSKm1 is a derivative of the E. coli vector pUC18, which is described in Yanish-Perron, C. et al. (Gene 33, 103-119 (1985)), in which the kanamycin resistance gene of the transposon Tn 903 was inserted.
0025This and other pendulum vectors based on pGA1 are not only stable in coryneform bacteria, in particular Corynebacterium glutamicum, but also coexist with plasmids of other origin, such as e.g. B. pHM1519 from Corynebacterium glutamicum ATCC 13058 and pAM 330 from Brevibacterium lactofermentum ATCC 13869, in particular with pCC1 from Corynebacterium callunae DSM 20147.
0026This is also surprising because, in the cases mentioned, it is a plasmid or a vector with a high copy number.
0027The proof was made in this way: Brevibacterium lactofermentum ATCC 13869, which carries the plasmid pAM 330, was transformed with pHS2-1-DNA as described in Thierbach et al. (Appl. Microbiol. Biotechnol. 29, 356-362 (1988)).
0028Examination of the transformants showed that both plasmids can coexist.
0029A mobilizable derivative of the plasmid pGA1 was introduced into Corynebacterium glutamicum ATCC13058, which carries the plasmid pHM1519, using the conjugation method as described in Schäfer et al. (J. Bact. 172, 1663-1666 (1990)). Examination of the transconjugants showed that both plasmids can coexist.
0030The plasmid pGA2 is also suitable for the construction of mobilizable pendulum vectors. The pendulum vector pFBH2, which replicates in Corynebacterium glutamicum, is constructed from a DNA sequence of pGA2 and the mobilizable E. coli vector pK18 :: mob.
1.
Isolation and characterization of pGA1 from Corynebacterium glutamicum LP-6
0031Corynebacterium glutamicum strain LP-6 was obtained from the "Felix d'Hérelle Reference Center for Bacterial Viruses" in Quebec 3 10, Quebec Laval University, Canada G1K 7P4 under the number HER1229. C. glutamicum strain LP-6 was deposited with the German Collection of Microorganisms in Braunschweig, Federal Republic of Germany, according to the Budapest Treaty as DSM5816.
0032Plasmid DNA was obtained from strain LP-6 according to methods known to the person skilled in the art, as described, for example, in European patent application 0 318 663 and in Birnboim, HC and Doly, J. (Nucleic Acids Research 7, 1513-1523 (1979)) are isolated. The DNA solution obtained in this way was characterized by agarose gel electrophoresis (Maniatis, T. et al. (1982), Molecular Cloning: A Laboratory Manual, Cold Spring Harbor). The DNA solution contained two species of plasmid, designated pGA1 and pGA2. Plasmid pGA1 is approximately 4.9 Kb in length and plasmid pGA2 is approximately 19.5 Kb in length. Treatment with the restriction enzyme SalI cleaved plasmid pGA2 while pGA1 remained intact.
0033The resulting DNA solution was subjected to CsCl / ethidium bromide density gradient centrifugation (Maniatis, T. et al. (1982), Molecular Cloning: A Laboratory Manual, Gold Spring Harbor) and the plasmid pGA1 was isolated in this way.
0034Plasmid pGA1 was treated with the restriction enzymes ApaI, BamHI, BclI, BglI, BglII, BstEII, ClaI, DraI, EcoRI, EcoRV, HindIII, KpnI, MluI, PvuII, SalI, SphI, SstI, XbaI and XhoI and the length of the DNA Fragments determined by agarose gel electrophoresis and length comparison with standard DNA fragments known to the person skilled in the art. One such standard is, for example, DNA from Escherichia coli phage λ which has been cleaved with the restriction enzyme HindIII and can be obtained from the company Bethesda Research Laboratories in Gaithersburg, USA. Table 1 shows the number of restriction sites in plasmid pGA1 for the restriction enzymes examined and the length of the DNA fragments obtained. By digesting pGA1 with two and three restriction enzymes and determining the length of the DNA fragments obtained, a restriction map of the plasmid could be drawn up, which is shown in FIG. 1. Plasmid pGA1 has a length of 4.9 Kb.
0035The copy number of pGA1 in strain LP-6 was determined as follows: strain LP-6 was cultivated in standard I broth (obtained from Merck, Darmstadt, FRG) until the beginning of the stationary growth phase and the cell number was determined. The plasmid DNA was isolated from 1.5 ml culture suspension as described in Birnboim, HC and Doly, J. (Nuclear Acids Research 7, 1513-1523 (1979)). An aliquot of the plasmid DNA solution and a known amount of the λ-HindIII DNA standard described above were subjected to agarose gel electrophoresis followed by ethidium bromide staining. The fluorescence under UV irradiation of the pGA1-DNA band was compared with that of the λ-HindIII-DNA fragments and the amount of pGA1-DNA was thus determined semi-quantitatively. In this way, the number of copies (number of plasmid molecules per cell) was determined to be approximately 50.
2.
Isolation and characterization of pGA2 from Corynebacterium glutamicum LP-6
0036A plasmid DNA-containing solution with the plasmids pGA1 and pGA2 was prepared as described under 1. The two plasmid species were separated by agarose gel electrophoresis and plasmid pGA2 was isolated by electroelution (Maniatis, T. et al, (1982), Molecular Cloning: A Laboratory Manual, Cold Spring Harbor).
0037Plasmid pGA2 was treated with the restriction enzymes EcoRI, BamHI, KpnI, ScaI, HpaI, MluI, SmaI, HindIII and XhoI and the length of the DNA fragments was determined as described under 1. Table 2 shows the number of restriction sites in plasmid pGA2 for the restriction enzymes examined and the length of the DNA fragments obtained. By digesting pGA2 with two and three restriction enzymes and determining the length of the DNA fragments obtained, a restriction map of the plasmid could be drawn up, which is shown in FIG. Plasmid pGA2 is 19.5 kb in length.
0038The copy number of pGA2 in strain LP-6 was determined as follows: strain LP-6 was cultivated in standard I broth (obtained from Merck, Darmstadt, FRG) until the beginning of the stationary growth phase and the cell number was determined. The plasmid DNA was isolated from 1.5 ml culture suspension as described in Birnboim, HC and Doly, J. (Nucleic Acids Research 7, 1513-1523 (1979)). An aliquot of the plasmid DNA solution and a known amount of the λ-HindIII DNA standard described above were subjected to agarose gel electrophoresis followed by ethidium bromide staining. The fluorescence under UV irradiation of the pGA2-DNA band was compared with that of the λ-HindIII-DNA fragments and the amount of pGA2-DNA was thus determined semi-quantitatively. In this way, the number of copies (number of plasmid molecules per cell) was determined to be approximately 5.<tables id="tabl0004" num="0004"><img file="EP0472869A2_D0001.tif" /></tables>
3.
Construction of the pendulum vector pHS2-1 consisting of pGA1 and the Escherichia coli vector pHSKm1
0039Plasmid pHSKm1 is a derivative of the E. coli vector pUC18 known to the person skilled in the art, which was described by Yanisch-Perron, C. et al. (Gene 33, 103-119 (1985)) and is available from Pharmacia in Uppsala, Sweden, in which the kanamycin resistance gene of transposon Tn903 (Oka, A. et al, J. Mol. Biol. 147, 217 -226 (1981)).
0040Plasmid pHSKm1 was constructed as described below. Plasmid pAGYC177, which carries the kanamycin resistance gene of the transposon Tn903 (Rose, RE; Nucleic Acids Research 16, 356 (1988)), was isolated from Escherichia coli ATCC37031 as described in EPA 0 316 663. Plasmid pACYC177 was digested with the restriction enzyme HaeII and the 1430 bp DNA fragment carrying the kanamycin resistance gene was electroeluted (Maniatis, T. et al, (1982) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor) isolated. Plasmid pUC18 was partially digested with HaeII, mixed with the 1430 bp HaeII DNA fragment and the resulting DNA mixture treated with T4 DNA ligase. Competent cells from Escherichia coli DH5α, which were obtained from Bethesda Research Laboratories in Gaithersburg, USA, were transformed with the ligation mixture. Kanamycin-resistant transformants were selected on LB agar (tryptone: 10 g / l; yeast extract: 5 g / l; Nacl: 10 g / l; agar: 12 g / l), which had been supplemented with 20 µg / ml kanamycin . The plasmid designated pHSKm1 was isolated from a transformant. The position and orientation of the inserted 1430 bp DNA fragment with the kanamycin resistance gene was determined by restriction analysis. The restriction map of the plasmid pHSKm1 is shown in Figure 3.
0041Plasmid pGA1, which is described under 1., was partially digested with the restriction enzyme Sau3A and the linearized and cut form of the plasmid was isolated by electroelution. The DNA thus obtained was mixed with pHSKm1-DNA which had been linearized with BamHI, and the resulting DNA mixture was treated with T4-DNA ligase. Escherichia coli DH5α was transformed with the ligation mixture and transformants were selected on LB agar containing Kanamycin (20 ug / ml), X-Gal (5-bromo-4-chloro-3-indolyl-D-galactopyranoside, 40 ug / ml and IPTG (isopropyl-β-D-thiogalactopyranoside, 20 µg / ml), and about 5% of the transformants were colorless on the agar described. Colony hybridization with plasmid pGA1 as a probe was performed with approximately 900 transformants that showed no lacZα complementation. For colony hybridization, pGA1 was translated using "nick" translation (Maniatis, T. et al. (1982), Molecular Cloning: A Laboratory Manual, Cold Spring Harbor) labeled with biotinylated nucleoside triphosphates (Biotin-7-dATP) and detected by means of the streptavidin-coupled alkaline phosphatase using the BluGENE nucleic acid detection system from Bethesda Research Laboratories in Gaithersburg, USA . The labeling of the DNA was carried out as in Langer et al. (Proceedings of the National Academy of Sciences, USA, 80, 6633-6637 (1981)) and colony hybridization as described in Trevor, GT (Microbiological Methods 3, 259 pp. (1985)). Of the 900 transformants tested, 70 gave a positive reaction. The plasmid designated pHS2-1 was isolated from a transformant and mapped with the aid of restriction enzymes. The restriction map of plasmid pHS2-1 is shown in Figure 4.
4.
Replication of the pendulum vector pHS2-1 in Corynebacterium glutamicum ATCC13032
0042Plasmid pHS2-1 was isolated from Escherichia coli DH5α / pHS2-1 and spheroplasts from Corynebacterium glutamicum ATCC13032, as described by Thierbach et al. (Appl. Microbiol. Biotechnol. 29, 356-362 (1988)), thus transformed. Transformants were selected on SB agar containing kanamycin (15 µg / ml). Plasmid DNA was isolated from 12 transformants and characterized by cleavage with the restriction enzymes EcoRI and MluI. The plasmid DNA was the same size and showed the same restriction pattern as pHS2-1 isolated from Escherichia coli.
5.
Stability of the pendulum vector pHS2-1 in Corynebacterium glutamicum ATCC13032
0043Corynebacterium glutamicum ATCC13032 / pHS2-1 was in standard I nutrient broth (obtained from Merck, Darmstadt, FRG), which had been supplemented with 4 g / l glucose and additionally with 10 µg / ml kanamycin, at 30 ° C and 150 rpm cultivated until the stationary growth phase is reached. A 50 ml culture consisting of the nutrient medium described above with kanamycin and a 50 ml culture consisting of the nutrient medium described above without kanamycin were inoculated in a ratio of 1: 10,000 with the preculture and, as described above, cultivated until the stationary growth phase was reached . The optical density of the bacterial culture was 7 to 8 at a measuring wavelength of 660 nm.
0044The kanamycin-containing bacterial culture was then inoculated in a ratio of 1: 10,000 to fresh kanamycin-containing nutrient broth, and the bacterial culture which had grown in the absence of kanamycin was inoculated in the same proportion to fresh kanamycin-free nutrient broth. A total of 16 such vaccinations were carried out, so that the strain was cultivated for approx. 210 generations in the presence or in the absence of kanamycin. Thereafter, samples were plated on standard I agar (obtained from Merck, Darmstadt, Germany) and incubated at 30 ° C. The individual colonies which formed were stamped on standard I agar and on standard I agar which had been supplemented with 10 μg / ml kanamycin. In the case of culture for 210 generations in the absence of kanamycin, 181 out of 181 individual colonies examined were kanamycin-resistant, and in the case of culture in the presence of kanamycin, 84 out of 84 individual colonies examined were kanamycin-resistant. Plasmid DNA was isolated from 12 individual colonies in each case and characterized by cleavage with the restriction enzymes EcoRI and MluI. The plasmid DNA was the size of pHS2-1 and showed the restriction pattern characteristic of pHS2-1.
6.
Coexistence of the plasmid pCC1 from Corynebacterium callunae DSM20147 with the pendulum vector pHS2-1
0045Corynebacterium callunae DSM20147 was treated with pHS2-1 plasmid DNA isolated from Corynebacterium glutamicum ATCC13032 / pHS2-1 as described by Thierbach et al. (Appl. Microbiol. Biotechnol. 29, 356-362 (1988)). Transformants were selected on SB agar containing kanamycin (15 µg / ml). 20 transformants were separated on standard I nutrient agar which had been supplemented with kanamycin (10 μg / ml). A single colony was removed and plasmid DNA isolated. The plasmid pCC1 was detected in 17 out of 20 individual colonies of the type DSM20147 / pHS2-1 examined by agarose gel electrophoresis; Plasmid pHS2-1 was present in all clones examined.
0046In the same way, spheroplasts of Corynebacterium callunae DSM20147 were produced as a control and regenerated on SB agar. 20 regenerated single colonies were separated on standard I nutrient agar. A single colony was removed and plasmid DNA isolated. The plasmid pCC1 was detected in 17 of 20 individual colonies of the type DSM20147 examined. A transformant of the type DSM20147 / pHS2-1 was used for approximately 50 generations in Absence of kanamycin - as described under 5. - cultivated. The two cultures were then plated on standard I agar and incubated at 30 ° C. Plasmid DNA was isolated from 8 individual colonies each. The plasmids pCC1 and pHS2-1 were detected in 8 of the 8 colonies examined. In the same way, the control was cultivated a regenerated single colony of strain DSM20147 for approximately 50 generations and then isolated from the plasmid DNA from 8 single colonies. The plasmid pCC1 was detected in 8 out of 8 individual colonies examined. The investigation showed that the plasmids pCC1 and pHS2-1 can coexist.
7.
Elimination of L-lysine by Corynebacterium glutamicum strain LP-6
0047Strain LP-6 was cultured in a medium consisting of 12 g / l ammonium sulfate, 240 g / l molasses and 60 ml / l soybean meal hydrolyzate, the pH of which had been adjusted to about 7.2 with ammoniacal water. 100 ml Erlenmeyer flasks were filled with 10 ml of the medium described above, inoculated with strain LP-6 and incubated for 72 hours at 30 ° C. and 300 rpm. L-lysine was determined in the centrifuged supernatant using amino acid analyzers. The excreted concentration of L-lysine · HCl was 0.9 g / l.
8.
Construction of the mobilizable pendulum vector pFBH2 consisting of a DNA sequence from pGA2 and the mobilizable Escherichia coli vector pK18 :: mob
0048Plasmid pK18 :: mob is a derivative of the Escherichia coli cloning vector pK18 known to the person skilled in the art (Pridmore, RD, Gene 56, 309-312 (1987)). Plasmid pK18 :: mob carries the region of the self-transferable plasmid RP4 essential for mobilization (Datta, N. et al., J. Bact. 108, 1244-1249 (1971)) and was constructed as follows: Plasmid pSUP102, which represents the mobilization region of the plasmid RP4 (Simon, R. et al., Methods in Enzymology 118, 640-659 (1986)), was converted from Escherichia coli S17-1 (Simon, R. et al., Biotechnology 1, 784-794 (1983)) according to methods familiar to the person skilled in the art, such as For example, in Holmes, DS & Quigley, M. (Analyt. Biochem. 114, 193-197 (1981)), isolated and partially cleaved with the restriction enzyme AluI. Plasmid pK18 was partially digested with the restriction enzyme NaeI, combined with the DNA fragments obtained by AluI digestion of the plasmid pSUP102 and the resulting DNA mixture was treated with T4 DNA ligase. Competent cells from Escherichia coli S17-1, which according to the protocol of Cohen, S, et al. (Proc. Natl. Acad. Sci. USA 69, 2110-2114 (1972)) were transformed with the ligation mixture and the cells on PA agar consisting of 17.5 g / l Penassay-Broth (Difco Laboratories, Detroit, USA) and 15 g / l Agar applied to which kanamycin had been added at a final concentration of 25 µg / ml. Kanamycin-resistant colonies were washed off with PA liquid medium and grown in a larger amount of PA liquid medium and according to standard methods, as in Simon, R. et al. (Biotechnology 1, 784-794 (1983)), used for crossing with Escherichia coli MM294 (Talmadge, K. and Gilbert, W., Gene 12, 235-241 (1980)). From the transconjugants grown on selection medium (PA agar with 25 µg / ml kanamycin and 50 µg / ml nalidixic acid), derivatives of the plasmid pK18 could be isolated which carried inserts of pSUP102-DNA. The vector referred to here as pK18 :: mob carries a pSUP102 insertion of 1.1 kb in length. The position of the inserted DNA fragment with the mobilization region was determined by restriction analysis. The restriction map of the plasmid pK18 :: mob is shown in Figure 5.
0049Plasmid pGA2, which is described under 2., was cleaved with the restriction enzyme HindIII and the resulting pGA2 DNA fragments were mixed with the plasmid vector pK18 :: mob, which had previously been linearized with HindIII. The resulting DNA mixture was treated with T4 DNA ligase and then used to transform Escherichia coli DH5α. Transformants were selected on LB agar which had been supplemented with kanamycin (20 ug / ml), X-Gal (40 ug / ml) and IPTG (20 ug / ml). All colorless colonies were checked for plasmid content using plasmid preparations known to the person skilled in the art, as described, for example, in Birnboim, HC and Doly, J. (Nucleic Acids Research 7, 1513-1523, (1979)) and the plasmids with the aid of characterized by restriction enzymes. One of the plasmids isolated carried a 5.7 kb pGA2 insert and was designated pFBH2. The restriction map of pFBH2 is shown in Figure 6.
9.
Replication of the pendulum vector pFBH2 in Corynebacterium glutamicum RM3
0050Escherichia coli S17-1 was transformed with pFBH2-DNA - isolated from DH5α / pF8H2 -, and the resulting transformants were selected on LB agar with kanamycin (20 μg / ml). A transformant of the type S17-1 / pFBH2 was used for conjugation with Corynebacterium glutamicum RM3, as described by Schäfer et al. (J. Bact. 172, 1663-1666, (1990)). C. transconjugants glutamicum RM3 were selected on LB agar which had been supplemented with kanamycin (20 µg / ml) and nalidixic acid (50 µg / ml). Plasmid DNA was isolated from 12 transconjugants and characterized by cleavage with various restriction enzymes. The isolated plasmid DNA was the same size and showed the same restriction pattern as pFBH2 isolated from Escherichia coli.
Description of the figures
0051<dl id="dl0001"><dt>Fig. 1:</dt><dd>Restriction map of plasmid pGA1 in a linear representation. Abbreviation: Ba, BamHI; B, BstEII; C, ClaI; E, EcoRI; H, Hind III; M, MluI; Pv, PvuII; S, SphI; X, XbaI.</dd><dt>Fig. 2:</dt><dd>Restriction map of plasmid pGA2 in a linear representation. Abbreviations: Ba, BamHI; E, EcoRI; Hp, HpaI; K, KpnI; Sc, ScaI.</dd><dt>Fig. 3:</dt><dd>Restriction map of the plasmid pHSKml in circular representation. The multiple cloning site extends between positions 400 to 452, abbreviations: amp, ampicillin resistance gene; Kan, kanamycin resistance gene; lacZ ', 5'-terminal part of the lacZ gene which allows lacZα complementation; ori, origin of replication.</dd><dt>Fig. 4:</dt><dd>Restriction map of the plasmid pHS2-1 in linear representation. The pGA1 and the pHSKml part 1 are shown separately. The pGA1 part of pHS2-1 contains at least 6 HaeII restriction sites, which have not been shown. Abbreviations: Sa, Sau3A; all other abbreviations are explained in Fig. 1.</dd><dt>Fig. 5:</dt><dd>Restriction map of plasmid pK18 :: mob in circular representation. Abbreviations: Kan, Kanamycin resistance gene; lacZ-alpha, 5'-terminal part of the lacZ gene, which allows lacZα complementation; oriV, origin of replication; oriT, origin for the conjugative plasmid transfer (mobilization region). The DNA region between positions (2375, NaeI / AluI) and (1275, NaeI / AluI) carries 3 NaeI restriction sites that have not been mapped.</dd><dt>Fig. 6:</dt><dd>Restriction map of the plasmid pFBH2 in a linear representation. Abbreviations: Ba, BamHI; Bg, BgIII; E, EcoRI; EV, EcoRV; H, Hind III; K, KpnI; Pst, PstI; Sm, SmaI; S, SphI; Ssp, SspI; Sst, SstI; X, XbaI. The pGA2 part of the molecule is marked by gray shading and the pK18 :: mob part by hatching.</dd></dl>
10 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| DE102014201384A1 | Cited by | Germany | Applicant |
| DE102012201360A1 | Cited by | Germany | Applicant |
| DE102010029973A1 | Cited by | Germany | Applicant |
| EP2085482A1 | Cited by | European Patent Office (EPO) | Applicant |
| US9988624B2 | Cited by | United States of America | Applicant |
| WO2015158808A2 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| US11293029B2 | Cited by | United States of America | Applicant |
| US10883101B2 | Cited by | United States of America | Applicant |
| DE102007059248A1 | Cited by | Germany | Applicant |
| US10808243B2 | Cited by | United States of America | Applicant |
| EP3072971A1 | Cited by | European Patent Office (EPO) | Applicant |
| WO2012098042A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| EP1918378A1 | Cited by | European Patent Office (EPO) | Applicant |
| WO2010070086A2 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO2020016287A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO2025238040A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO2017100376A2 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| US10336998B2 | Cited by | United States of America | Applicant |
| DE102010019059A1 | Cited by | Germany | Applicant |
| EP2354235A1 | Cited by | European Patent Office (EPO) | Applicant |
| US11155808B2 | Cited by | United States of America | Applicant |
| US8153404B2 | Cited by | United States of America | Applicant |
| WO2022171827A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO2022171827A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| EP2431476A1 | Cited by | European Patent Office (EPO) | Applicant |
| EP4311857A2 | Cited by | European Patent Office (EPO) | Applicant |
| EP0625576A3 | Cited by | European Patent Office (EPO) | Search report |
| WO0171012A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US9005928B2 | Cited by | United States of America | Applicant |
| WO2014029592A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| EP2175024A2 | Cited by | European Patent Office (EPO) | Applicant |
| EP2479279A1 | Cited by | European Patent Office (EPO) | Applicant |
| WO2015140314A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| DE102007041862A1 | Cited by | Germany | Applicant |
| WO2014029592A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO2015158800A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| DE102018117233A1 | Cited by | Germany | Applicant |
| US7238502B2 | Cited by | United States of America | Applicant |
| WO2024231219A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO2018077701A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| US7244569B2 | Cited by | United States of America | Applicant |
| WO2025238041A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| US10544390B2 | Cited by | United States of America | Applicant |
| WO0171012A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US10047358B1 | Cited by | United States of America | Applicant |
| EP1076094A2 | Cited by | European Patent Office (EPO) | Search report |
| DE102007027006A1 | Cited by | Germany | Applicant |
| DE102010032484A1 | Cited by | Germany | Applicant |
| EP0625576A2 | Cited by | European Patent Office (EPO) | Search report |
| EP1908842A2 | Cited by | European Patent Office (EPO) | Applicant |
| US11155807B2 | Cited by | United States of America | Applicant |
| EP1942198A2 | Cited by | European Patent Office (EPO) | Applicant |
| US8906653B2 | Cited by | United States of America | Applicant |
| EP1921150A1 | Cited by | European Patent Office (EPO) | Applicant |
| US10457933B2 | Cited by | United States of America | Applicant |
| WO2013152913A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO03100072A2 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| US6777229B1 | Cited by | United States of America | Applicant |
| US11312951B2 | Cited by | United States of America | Applicant |
| EP1908841A1 | Cited by | European Patent Office (EPO) | Applicant |
| US11352621B2 | Cited by | United States of America | Applicant |
| DE102012007491A1 | Cited by | Germany | Applicant |
| EP3418388A1 | Cited by | European Patent Office (EPO) | Applicant |
| WO0104325A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| EP2479279A1 | Cited by | European Patent Office (EPO) | Applicant |
| US7785846B2 | Cited by | United States of America | Applicant |
| EP2952585A1 | Cited by | European Patent Office (EPO) | Applicant |
| US7282357B2 | Cited by | United States of America | Applicant |
| EP1076094A3 | Cited by | European Patent Office (EPO) | Search report |
| US11208649B2 | Cited by | United States of America | Applicant |
| DE102010014680A1 | Cited by | Germany | Applicant |
| WO2012098042A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| DE102008002715A1 | Cited by | Germany | Applicant |
| US8338141B2 | Cited by | United States of America | Applicant |
| EP1097998A1 | Cited by | European Patent Office (EPO) | Search report |
| US11085040B2 | Cited by | United States of America | Applicant |
| WO2011154503A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO2018226964A2 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO2011138006A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| DE102013202106A1 | Cited by | Germany | Applicant |
| WO2016151054A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO2015158800A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO2019154984A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| US6905819B1 | Cited by | United States of America | Applicant |
| EP2949214A1 | Cited by | European Patent Office (EPO) | Applicant |
| EP2952584A1 | Cited by | European Patent Office (EPO) | Applicant |
| US7585650B2 | Cited by | United States of America | Applicant |
| DE102007060705A1 | Cited by | Germany | Applicant |
| EP2700715A1 | Cited by | European Patent Office (EPO) | Applicant |
| US7381549B2 | Cited by | United States of America | Applicant |
| WO2024231217A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO2018178126A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| US9388439B2 | Cited by | United States of America | Applicant |
| WO2015110518A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO2020002494A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| WO2016131801A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| US10647980B2 | Cited by | United States of America | Applicant |
| WO2018077700A1 | Cited by | World Intellectual Property Organization (WIPO) | Applicant |
| EP2243790A1 | Cited by | European Patent Office (EPO) | Applicant |
| US10968445B2 | Cited by | United States of America | Applicant |
4 priority claims, no other members on record
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 4027453 | Germany | A | |
| 4027453 | Germany | – | |
| DE19904027453 | – | – | – |
| 4027453 | – | – | – |
43 legal events, as 3 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Nl: lapsed or anulled due to non-payment of the annual feeLapsedNLV4 | NLV4 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Transmission of propertyTP | TP | FR | |
| Nl: assignments of ep-patentsNLS | NLS | EP | |
| Nl: assignments of ep-patentsNLS | NLS | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Ep patent lapsedLapsedEBP | EBP | DK | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Be: lapsedLapsedBERE | BERE | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Se: european patent in force in swedenEAL | EAL | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| It: last paid annual feeITTA | ITTA | EP | |
| Gb: translation of ep patent filed (gb section 77(6)(a)/1977)GBT | GBT | EP | |
| Ep patent with danish claimsT3 | T3 | DK | |
| Fr: translation filedET | ET | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0472869
- Publication, DOCDB
- 0472869
- Publication, EPODOC
- EP0472869
- Application
- 91111532
- Application, DOCDB
- 91111532
- Application, EPODOC
- EP19910111532
Titles6
- German
- Neue Plasmide aus Corynebacterium glutamicum und davon abgeleitete Plasmidvektoren.
- English
- Plasmids of corynebacterium glutamicum and derived plasmid vectors.
- French
- Plasmides de corynebacterium glutamicum et vecteurs plasmidiques dérivés.
- German
- Neue Plasmide aus Corynebacterium glutamicum und davon abgeleitete Plasmidvektoren
- English
- Plasmids of corynebacterium glutamicum and derived plasmid vectors
- French
- Plasmides de corynebacterium glutamicum et vecteurs plasmidiques dérivés
Classification
- CPC, 3
- C12P13/08
- C12N15/77
- Y10S435/843
- IPC, 5
- C12N1 21
- C12N15 09
- C12N15 77
- C12P13 08
- C12R1 15
Designated states8
- Contracting states, 8
- Belgium
- Germany
- Denmark
- France
- United Kingdom
- Italy
- Netherlands (Kingdom of the)
- Sweden